Back
Consumer Discretionary Select Sector SPDR Fund Vs. Novo Nordisk AS Industry Stock Comparison
Buy
75
XLY
Consumer Discretionary Select Sector SPDR Fund
Last Price:
$228.83
Seasonality Move:
1.44%
Sell
13
NONOF
Novo Nordisk AS
Last Price:
$84.75
Seasonality Move:
6.94%
Buy
75
Consumer Discretionary Select Sector SPDR Fund (XLY)
is a Buy
Is Consumer Discretionary Select Sector SPDR Fund a Buy, Sell or Hold?
-
The current Consumer Discretionary Select Sector SPDR Fund [XLY] share price is $228.91. The Score for XLY is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
XLY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
13
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
XLY Stock Price Chart
What is Consumer Discretionary Select Sector SPDR Fund's stock price today?
-
The Consumer Discretionary Select Sector SPDR Fund share price today is $228.91The current trend is moderately bullish and XLY is experiencing slight selling pressure.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $84.75Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
XLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.15 | Buy |
| Relative Strength Index (14 RSI): | 56.08 | Buy |
| Chaikin Money Flow: | -145573 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (217.93 - 233.77) | Buy |
| Bollinger Bands (100): | (183.91 - 218.93) | Buy |
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.51 | Sell |
| Relative Strength Index (14 RSI): | 24.55 | Sell |
| Chaikin Money Flow: | 64911 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (100.57 - 111.43) | Sell |
| Bollinger Bands (100): | (107.18 - 131.16) | Sell |
XLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 233.82 | Sell |
| 20-day SMA: | 228.61 | Buy |
| 50-day SMA: | 214.65 | Buy |
| 200-day SMA: | 190.97 | Buy |
| 8-day EMA: | 231.56 | Sell |
| 20-day EMA: | 228.05 | Buy |
| 50-day EMA: | 217.61 | Buy |
| 200-day EMA: | 195.33 | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.03 | Sell |
| 20-day SMA: | 106.85 | Sell |
| 50-day SMA: | 109.33 | Sell |
| 200-day SMA: | 126.14 | Sell |
| 8-day EMA: | 102.09 | Sell |
| 20-day EMA: | 105.65 | Sell |
| 50-day EMA: | 110.06 | Sell |
| 200-day EMA: | 118.01 | Sell |
Consumer Discretionary Select Sector SPDR Fund Earnings Growth & XLY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
Consumer Discretionary Select Sector SPDR Fund Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk AS Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||